ALEXANDRIA, Va., March 19 -- United States Patent no. 12,252,550, issued on March 18, was assigned to DIANTHUS THERAPEUTICS OPCO INC. (New York).
"Antibodies that bind to C1S and uses thereof" was invented by Vahe Bedian (Waltham, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Embodiments that are provided for herein relate to antibodies and compositions that bind to C1s. Also provided are methods of producing the antibodies of the present disclosure, as well as uses of the provided antibodies and compositions for the treatment of C1s mediated diseases and disorders."
The patent was filed on May 20, 2022, under Application No. 17/749,362.
*For further information, including images, charts and tables,...